皇后大学贝尔法斯特(Belfast)的研究人员研究RNA在肠癌抗化疗方面的作用,目的是在早期发病病例增加的情况下改善治疗。 Researchers at Queen’s University Belfast study RNA's role in bowel cancer's resistance to chemotherapy, aiming to improve treatments amid rising early-onset cases.

皇后大学贝尔法斯特(Belfast)的研究人员在英国癌症研究的支持下,正在研究肠癌如何发展对化疗的抗药性,重点研究RNA在帮助癌症细胞修复遗传毒性药物损害方面的作用。 Researchers at Queen’s University Belfast, backed by Cancer Research UK, are studying how bowel cancer develops resistance to chemotherapy, focusing on RNA's role in helping cancer cells repair damage from genotoxic drugs. 该项目旨在发现治疗抗药性背后的机制,特别是随着25至49岁成年人的早发病例增加,情况尤其如此。 The project aims to uncover mechanisms behind treatment resistance, especially as early-onset cases rise among adults aged 25 to 49. 在联合王国,肠癌仍然是造成癌症死亡的第二大原因,北爱尔兰每年约有1 300个病例,近500人死亡。 Bowel cancer remains the second leading cause of cancer deaths in the UK, with about 1,300 cases and nearly 500 deaths annually in Northern Ireland. 研究结果可以导致更有效的治疗,改善面临抗药性疾病的患者的治疗结果。 The findings could lead to more effective therapies and improve outcomes for patients facing resistant disease.